Nanomedicine

Search results

• News Therapy targeting specific immune cells appears promising in sepsis

  Mulder, W.

  10/06/23

  1 item of Media coverage

  Press/Media

• Innovative Nanomedicine Offers New Hope for Sepsis Treatment, says Radboudumc and Eindhoven University of Technology

  Mulder, W.

  10/06/23

  1 item of Media coverage

  Press/Media

• Nanoparticle therapy targeting specific immune cells appears promising for sepsis

  Mulder, W., Teunissen, A. & Fayad, Z.

  9/06/23

  2 items of Media coverage

  Press/Media

• Specific Immune Cell Therapy Shows Promise for Sepsis Treatment

  Mulder, W., Teunissen, A. & Fayad, Z.

  9/06/23

  2 items of Media coverage

  Press/Media

• Eindhoven University of Technology: Therapy Targeting Specific Immune Cells Appears Promising for Sepsis

  Mulder, W., Teunissen, A. & Fayad, Z.

  9/06/23

  2 items of Media coverage

  Press/Media

• Therapy targeting specific immune cells appears promising for sepsis

  Mulder, W., Teunissen, A. & Fayad, Z.

  8/06/23

  1 item of Media coverage

  Press/Media

• Therapy targeting specific immune cells appears promising in sepsis Nanoparticles restore balance in dysregulated immune system

  Mulder, W., Teunissen, A. & Fayad, Z.

  8/06/23

  2 items of Media coverage

  Press/Media

• Studies from Eindhoven University of Technology Update Current Data on Information Technology (Dna Storage In Thermoresponsive Microcapsules for Repeated Random Multiplexed Data Access)

  Mulder, W.

  1/06/23

  1 item of Media coverage

  Press/Media

• This start-up trains the immune system to treat cancer more effectively

  Mulder, W.

  23/03/23

  1 item of Media coverage

  Press/Media

• This start-up trains the immune system to treat cancer more effectively

  Mulder, W.

  21/03/23

  1 item of Media coverage

  Press/Media

• Roy van der Meel: I'm a kind of postie who delivers medicines

  Mulder, W.

  27/12/22

  4 items of Media coverage

  Press/Media

• Studies from Radboud University Nijmegen Yield New Data on Medullary Thyroid Cancer (Reprogramming of Myeloid Cells and Their Progenitors In Patients With Non-medullary Thyroid Carcinoma)

  Mulder, W.

  17/11/22

  1 item of Media coverage

  Press/Media

• Recent Findings in Life Science Described by Researchers from Icahn School of Medicine at Mount Sinai (Trained Immunity - Basic Concepts and Contributions To Immunopathology)

  Mulder, W. & Ochando, J.

  10/11/22

  1 item of Media coverage

  Press/Media

• Willem Mulder appointed professor of Precision Medicine

  Mulder, W.

  4/10/22

  1 item of Media coverage

  Press/Media

• Willem Mulder appointed professor of Precision Medicine

  Mulder, W.

  4/10/22

  1 item of Media coverage

  Press/Media

• Australia Patent: ICahn School of Medicine at Mount Sinai Files Application for 'TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS'

  Mulder, W., Ochando, J. & Fayad, Z.

  16/09/22

  1 item of Media coverage

  Press/Media

• Australian Patent Office Grants Patent for 'Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis'

  Mulder, W., Ochando, J. & Fayad, Z.

  29/07/22

  1 item of Media coverage

  Press/Media

• Australia Patent: ICahn School of Medicine at Mount Sinai Files Application for 'TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS'

  Mulder, W., Ochando, J. & Fayad, Z.

  15/07/22

  1 item of Media coverage

  Press/Media

• Australia: Icahn School of Medicine at Mount Sinai Receives Patent for 'Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis'

  Mulder, W., Ochando, J. & Fayad, Z.

  1/04/22

  1 item of Media coverage

  Press/Media

• Immune Cells That Remember Inflammation Could Offer Treatment Targets for Atherosclerosis

  Mulder, W.

  1/12/21

  1 item of Media coverage

  Press/Media

• Banning journal impact factors is bad for Dutch science

  Mulder, W.

  3/08/21

  1 item of Media coverage

  Press/Media

• TU/e and Radboudumc join forces with creation of biomedical platform Biotrip

  Mulder, W.

  7/07/21

  1 item of Media coverage

  Press/Media

• Eindhoven University of Technology and Radboudumc Join Forces With Creation of Biomedical Platform Biotrip

  Mulder, W.

  30/06/21 → 1/07/21

  2 items of Media coverage

  Press/Media

• TU/e and Radboudumc join forces with creation of biomedical platform Biotrip

  Mulder, W.

  30/06/21

  1 item of Media coverage

  Press/Media

• -Eindhoven University of Technology: Major EU grants for groundbreaking research into scoliosis and transplant organ rejection

  Mulder, W.

  23/04/21

  1 item of Media coverage

  Press/Media